ALB and Alzheimer disease: Furthermore, studies have validated the association between in vivo imaging measurements from DCE MRI with both ASL MRI and CSF biomarkers such as albumin, indicating the potential of these techniques to predict AD progression (Montagne et al., 2015, 2022; van de Haar et al., 2016b; Varatharaj et al., 2019; Shao et al., 2020; Gold et al., 2021).